BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Shi Y, Song Y, Duan D, Zhang X, Sun K, Li Y. Tf ligand-receptor-mediated exenatide-Zn 2+ complex oral-delivery system for penetration enhancement of exenatide. Journal of Drug Targeting 2018;26:931-40. [DOI: 10.1080/1061186x.2018.1455839] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Choy C, Lim LY, Chan LW, Cui Z, Mao S, Wong TW, Page C. Exploring Intestinal Surface Receptors in Oral Nanoinsulin Delivery. Pharmacol Rev 2022;74:960-81. [DOI: 10.1124/pharmrev.122.000631] [Reference Citation Analysis]
2 Guo M, He Z, Jin Z, Huang L, Yuan J, Qin S, Wang X, Cao L, Song X. Oral nanoparticles containing naringenin suppress atherosclerotic progression by targeting delivery to plaque macrophages. Nano Res . [DOI: 10.1007/s12274-022-4808-2] [Reference Citation Analysis]
3 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
4 Zhang J, Liu X, Lin J, Bao X, Peng J, Gong Z, Luan X, Chen Y. Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121979] [Reference Citation Analysis]
5 Wang P, Wang Y, Li P, Chen C, Ma S, Zhao L, He H, Yin T, Zhang Y, Tang X, Gou J. Oral delivery of polyester nanoparticles for brain-targeting: Challenges and opportunities. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.07.034] [Reference Citation Analysis]
6 Arora M, Zou D, Ravi Kumar M. Nanoparticle-assisted oral delivery of small and large peptides. Oral Delivery of Therapeutic Peptides and Proteins 2022. [DOI: 10.1016/b978-0-12-821061-1.00007-1] [Reference Citation Analysis]
7 Brayden DJ, Hill TA, Fairlie DP, Maher S, Mrsny RJ. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches. Adv Drug Deliv Rev 2020;157:2-36. [PMID: 32479930 DOI: 10.1016/j.addr.2020.05.007] [Cited by in Crossref: 93] [Cited by in F6Publishing: 96] [Article Influence: 31.0] [Reference Citation Analysis]
8 Zhang X, Zhao L, Zhai G, Ji J, Liu A. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma. Med Sci Monit 2019;25:9737-51. [PMID: 31856143 DOI: 10.12659/MSM.918899] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
9 Pinho AR, Fortuna A, Falcão A, Santos AC, Seiça R, Estevens C, Veiga F, Ribeiro AJ. Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices. J Pharm Anal 2019;9:143-55. [PMID: 31297291 DOI: 10.1016/j.jpha.2019.02.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
10 Shreya AB, Raut SY, Managuli RS, Udupa N, Mutalik S. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances. AAPS PharmSciTech 2018;20:15. [PMID: 30564942 DOI: 10.1208/s12249-018-1262-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]